The TAVR procedure has revolutionized a challenging task in heart care: fixing stiff valves. And it has made the process much easier for patients, getting them back to an active life faster.

The heart’s four valves – the mitral, aortic, pulmonary, and tricuspid – open and close to move blood around the body. If a valve becomes damaged or stretched, it can also become leaky. This ...

Total sales grew 2.9% YoY to $5.4 billion (+0.3% vs. consensus) aided by Transcatheter Aortic Valve Replacement segment grew 2.8% YoY to $3.5 billion, Surgical Structural Heart division grew ...

Patients who underwent transcatheter aortic valve replacement (TAVR) with a valve designed to treat aortic regurgitation had an overall mortality rate of just 8.1% at one year, well below the ...

COLLEGEVILLE, Pa.--(BUSINESS WIRE)--Thubrikar Aortic Valve, Inc. today announced successful results in an additional 5 patients implanted with the Optimum Transcatheter Aortic Valve (Optimum TAV ...

Heart Hospital of Austin has worked toward less invasive procedures for patients, shifting from open-heart surgery to ...

DEAR DR. ROACH: I’ve had a leaky aortic valve for approximately six years. I recently had an echocardiogram using Doppler. The last test I received was three years ago, which came back with a ...

The device will be used to treat patients with symptomatic severe aortic stenosis who are at high or extreme risk for open-heart surgery. This week, a structural heart team composed of interventional ...

At baseline, the mechanical valve group tended to be younger (55.7 vs 65.2) and had less aortic stenois (82.4% vs 89.5%), but more moderate and severe aortic regurgitation (39.0% vs 30.5%).

In a fitting move for the maker of heart-valve-opening technology, California-based startup JenaValve has taken another step toward opening up the device’s pathway to the U.S. commercial market.